Tenofovir Renal Toxicity and Glomerular Filtration Rate (GFR) Validation
Incidence and Predictor of TDF Associated Nephrotoxicity and Pharmacokinetic of TDF in HIV-1 Infected Thai Patients: A Sub-study of HIV-NAT 006 Long Term Cohort
Sponsor: Chulalongkorn University
Listed as NCT01138241, this observational or N/A phase trial focuses on HIV Infection and Renal Function and remains completed. Sponsored by Chulalongkorn University, it has been updated 11 times since 2010, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 6 earlier versions
-
Sep 2019 — Nov 2020 [monthly]
Completed
-
Jun 2018 — Sep 2019 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
First recorded
Mar 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chulalongkorn University
- Kirby Institute
- The HIV Netherlands Australia Thailand Research Collaboration
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Bangkok, Thailand